Evaluate a Norstella company
Evaluate a Norstella company

On Demand Webinar

Orphan Drugs: A safe(r) passage amid stormy waters?

Amid wider turmoil, orphan drugs sales continue their steady rise.

Orphan drug sales are forecast to exceed $400 billion by 2032, accounting for 22% of global prescription drug sales. Yet momentum is uneven. Investor interest is still in the ‘big drugs’ camp, and policy turmoil remains despite some recent wins for orphans.

Share:

Watch now








About this webinar

In this webinar, Evaluate’s experts discuss the latest market outlook for rare disease drugs. Drawing on Evaluate’s orphan drug forecasts out to 2032, we examine the companies and assets best positioned to win, from fast growing franchises such as Argenx’s Vyvgart, to shifts in therapy area focus.

We Discuss

  • How orphan drug sales and pipelines are evolving amid uncertainty
  • Which companies and franchises are driving rare disease growth, and which are losing momentum
  • The impact of recent US policy shifts on orphan drug development, including the Inflation Reduction Act
  • What portfolio teams and investors must prioritize to compete for value in rare diseases in 2026 and beyond
Watch today

Speakers

mel-senior_headshot-cropped

Melanie Senior

Industry expert and author of the Evaluate Orphan Drug Report
Andreas Hadjivasiliou

Andreas Hadjivasiliou

Manager, Content Strategy, Evaluate

Explore all webinars

Webinar

April 2, 2026

World Preview 2026 Webinar

Discover

Webinar

March 12, 2026

Unlock Strategic Insights for Pharma: Custom Competitive Intelligence and Landscape Monitoring

Discover

Webinar

February 17, 2026

Orphan Drugs: A safe(r) passage amid stormy waters?

Discover

Webinar

December 18, 2025

Unlock the Secrets to Long Range Planning Success

Discover

Webinar

December 1, 2025

Inside #JPM2026: The Stories Behind the Summit

Discover

Webinar

November 20, 2025

2026 Preview Webinar

Discover

Webinar

November 20, 2025

Inside The Future of Pharma Forecasting

Discover

Webinar

November 18, 2025

Mastering Pharmaceutical Forecasting: Key Principles and Practical Insights

Discover

Webinar

October 23, 2025

Unlocking innovation: What Pharma deals reveal about tomorrow’s therapies

Discover

Webinar

September 30, 2025

Cliffhanger: Portfolio Tactics to Scale the $300bn Patent Cliff

Discover
Evaluate White Logo
Instagram Linkedin